WELCOME, N.C. – Richard Childress Racing announced Wednesday that AstraZeneca, a global science-based biopharmaceutical company, will sponsor select races for Austin Dillon in the NASCAR Cup Series.

AstraZeneca will feature the BREZTRI AEROSPHERE Inhalation Aerosol brand on Dillon’s No. 3 Chevrolet Camaro ZL1 1LE.

BREZTRI AEROSPHERE is a medicine used long term to treat chronic obstructive pulmonary disease (COPD), including chronic bronchitis, emphysema, or both, for better breathing and fewer flare-ups.

Dillon is a two-time NASCAR champion, with titles in the NASCAR Camping World Truck Series and the NASCAR Xfinity Series, as well as the 2017 Coca-Cola 600 winner and 2018 Daytona 500 champion.

He is in his eighth full-time season in the Cup Series driving the legendary No. 3 Chevrolet.

“There is a history of COPD in my family, so it’s really important to me to be able to help encourage patients to talk to their doctor about their health goals and to visit BREZTRI.com to learn about a treatment option,” said Dillon, whose paternal grandfather, Stan Dillon, suffered from COPD. “I look forward to running the BREZTRI colors on the No. 3 Chevrolet and thank AstraZeneca for its partnership.”

In addition to primary sponsorship on the No. 3 Chevrolet for select races this year, BREZTRI will also be featured as an associate partner for the full season.

“We’ve enjoyed our relationship with AstraZeneca for several years, so we are happy to continue our partnership in a new and innovative way with BREZTRI,” said Torrey Galida, President of Richard Childress Racing. “This is a special relationship for RCR and we are looking forward to a great season ahead.”